Basic Information

Drug ID DDPD12243 ...
Drug Name Edaravone
Molecular Weight 174.203
Molecular Formula C10H10N2O
CAS Number 89-25-8
SMILES CC1=NN(C(=O)C1)C1=CC=CC=C1
External Links
DRUGBANK DB12243
PubChem Compound 4021
PDR 24080

Experimental Physicochemical Property

Property Name Property Value Unit Raw Value Raw Unit Reference
Melting Point 129.7 129.7 FDA Label
Water Solubility 1000.0 mg/L <1 mg/ml MSDS
pKa 7.0 - 7 - Watanabe T, Tahara M, Todo S: The novel antioxidant edaravone: from bench to bedside. Cardiovasc Ther. 2008 Summer;26(2):101-14. doi: 10.1111/j.1527-3466.2008.00041.x. [A19140]

Pharmacokinetic/ Toxicokinetic Property

Property Name Property Value Unit Raw Value Raw Unit Annotation Factor Reference
Bioavailability 38.0 % 38 % PO, oral; mouse; DRUGBANK
C Max 888.0 ng/ml 888 ng/ml intravenous infusion, IV in drop; normal,healthy; Male, men; adults; DRUGBANK
Clearance 6.0 L/h 0.1 L/min Plasma clearance; intravenous infusion, IV in drop; Single dose; DRUGBANK
Clearance 0.0852 L/h/kg 1.42 ml/min/kg intravenous injection, IV; human, homo sapiens; Human Intravenous Pharmacokinetic Dataset
Volume of Distribution 18.5 L/kg 18.5 L/kg Average volume of distribution; intravenous infusion, IV in drop; DRUGBANK
Volume of Distribution 0.23 L/kg 0.23 L/kg intravenous injection, IV; human, homo sapiens; Human Intravenous Pharmacokinetic Dataset
Half-life 5.3 h 4.5-6 h elimination half-life; DRUGBANK
Half-life 2.4 h 2-2.8 h Metabolite; DRUGBANK
Half-life 2.4 h 2.36 h intravenous injection, IV; human, homo sapiens; Human Intravenous Pharmacokinetic Dataset
Toxicity LD50 1915.0 mg/kg 1915.0 mg/kg PO, oral; Rattus, Rat; DRUGBANK
Eliminate Route 0.80 % ~0.7-0.9 % Unchanged drug; DRUGBANK
Protein Binding 92.0 % 92 % high protein binding; human, homo sapiens; Plasma Concentration → ; DRUGBANK
Protein Binding 90.0 % 89-91 % high protein binding; human, homo sapiens; DRUGBANK

Maximum Dosage

Property Name Property Value Unit Raw Value Raw Unit Annotation Brand Name Component Reference
Max dose for adults 60.0 mg/day 60 mg/day intravenous injection, IV Radicava edaravone PDR
Max dose for geriatric 60.0 mg/day 60 mg/day intravenous injection, IV Radicava edaravone PDR

Drug Property Radar Chart

...

Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1